We have safety data from CD10, CD12 and long haulers, so
We have safety data from CD10, CD12 and long haulers, so even if you throw out the 8 years oh HIV, the drug is proven safe. The FDA is clearly messing with, but not just us. Many companies have complained about the FDA approving BP drugs with serious side effects while being slow walked by the FDA.
The evidence indicates why we can no longer trust the FDA to carry out its historic mission to protect the public from harmful and ineffective drugs. Strong public demand that government “do something” about periodic drug disasters has played a central role in developing the FDA.2 Yet close, constant contact by companies with FDA staff and officials has contributed to vague, minimal criteria of what “safe” and “effective” mean. The FDA routinely approves scores of new minor variations each year, with minimal evidence about risks of harm. Then very effective mass marketing takes over, and the FDA devotes only a small percent of its budget to protect physicians or patients from receiving biased or untruthful information.34 The further corruption of medical knowledge through company-funded teams that craft the published literature to overstate benefits and understate harms, unmonitored by the FDA, leaves good physicians with corrupted knowledge.5 6 Patients are the innocent victims
Remdesivir may cause serious allergic reactions, including infusion-related reactions and anaphylaxis, which can be life-threatening and require immediate medical attention.
Sorry, the FDA is messing with us.
4
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...
Continue Reading
AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...
Continue Reading
Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...
Continue Reading
Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....
Continue Reading
Out in Texas, folks facing iron deficiency have a new game-changer coming their way. Drip Gym, the same outfit making waves out in Queens and Long Island, is taking their mobile iron IV therapy clinic straight to Texan doorsteps. No more trotting off to a clinic for iron infusions with this crew rolling into Houston, Dallas, Austin, and San Antonio. What's the Big Deal?...
Continue Reading
A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...
Continue Reading
New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...
Continue Reading
Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...
Continue Reading
Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....
Continue Reading
Understanding What Constitutes Bad Faith Insurance What does it really mean when an insurer acts in "bad faith"? Well, the legal standard doesn't leave much wiggle room in California. These aren't just bad outcomes; we're talking about conduct that defies what's reasonable under state law. Demián I. Oksenendler, a seasoned bad faith attorney, shed some light on this in a...
Continue Reading
Top 5 Most Recently Viewed Articles
VinFast Reports Impressive Growth in Second Quarter of 2024 VinFast Auto Ltd. (NASDAQ: VFS), a subsidiary of Vingroup JSC, recently shared its unaudited financial results for the second quarter, showcasing a notable rise in electric vehicle (EV) deliveries and revenue. This development signals the company’s ongoing efforts to establish itself as Vietnam's only dedicated...
Continue Reading
Understanding the Federal Reserve's Position The global markets are gearing up for some significant shifts as the U.S. Federal Reserve is set to make crucial decisions about its key interest rate. There’s a mix of expectations; many are speculating whether the Fed will go for a 25 or 50 basis point rate cut. Recent fund futures indicate a marked increase in demand,...
Continue Reading
Significant Legal Actions Against Major Chip Manufacturers Intel Corp (NASDAQ: INTC), Advanced Micro Devices Inc (NASDAQ: AMD), and Texas Instruments Inc (NASDAQ: TXN) are embroiled in serious legal troubles, as they face multiple lawsuits. These lawsuits allege that these companies failed to ensure that their semiconductor products did not fall into the hands of Russian...
Continue Reading
Sun Life Financial Inc. Declares Dividends for Shareholders Today, the Board of Directors of Sun Life Financial Inc. (TSX: SLF) announced an important decision regarding dividends. The announcement is significant news for shareholders who look forward to consistent returns on their investments. The Board has declared a dividend of $0.92 per share on the common shares,...
Continue Reading
Significant Growth for Intelligent Bio Solutions Intelligent Bio Solutions Inc. (Nasdaq: INBS), a pioneering medical technology company specializing in rapid, non-invasive testing solutions, recently shared exciting news. The company successfully secured 33 new customer accounts during its fiscal first quarter, exemplifying a striking growth of 50% compared to the same...
Continue Reading